Targeting Pre-Leukemic Cells: New Hope for Preventing Childhood B-ALL
Researchers from Universidad Autónoma de Madrid published a new editorial in Oncotarget detailing a... read more
March 31, 2023
Oncotarget News
Unconventional Protein Secretion (UPS) in Cancer
Researchers from The Jikei University School of Medicine published a recent editorial perspective in Oncotarget,... read more
March 16, 2023
The Role of Kras and Canonical Wnt Pathways in Biliary Tract Cancers
In a recent Oncotarget editorial, researchers discuss Kras and the canonical Wnt pathway in biliary... read more
March 1, 2023
Oncotarget’s Top 10 Papers in 2022 (Crossref Data)
Crossref is a non-profit organization that logs and updates citations for scientific publications. Each month,... read more
February 22, 2023
Controlling Glycolytic Flux: Therapy Challenges and Solutions
In a new editorial paper, researchers from the University of Oxford explore challenges and potential... read more
February 16, 2023
The Importance of CD56 in the Fight Against Multiple Myeloma
In a new Oncotarget editorial, researchers discussed their study on CD56 in multiple myeloma.The... read more
February 2, 2023
Researchers Identify New Drug Candidates to Treat DLST+ Tumors
The increased expression of DLST has recently been associated with increased tumor aggression and a... read more
January 19, 2023
Novel Antibody Drug Conjugate Improves Murine Acute Myeloid Leukemia
Researchers from Astellas Pharma Inc. investigated the efficacy of a novel antibody drug conjugate combined... read more
January 4, 2023
A New Method of Targeting Exosomes in Precision Medicine
Oncotarget published a new editorial perspective by Dr. Mujib Ullah, entitled, "The future of bioorthogonal-chemistry... read more
December 20, 2022
Plasma Growth Hormone in HCC: A Biomarker of Response to Atezo/Bev?
In a new study, researchers investigated the plasma growth hormone as a potential biomarker of... read more
December 8, 2022